EC
DNTH icon

EcoR1 Capital’s Dianthus Therapeutics DNTH Stock Holding History

EcoR1 Capital’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-22,929
Closed -$3.59M – 73
2021
Q2 		$3.59M Sell
22,929
-11,843
-34% -$2.18M 0.13% 46
2021
Q1 		$6.59M Buy
+34,772
New +$5.85M 0.29% 38
2020
Q3 		– Sell
-28,125
Closed -$3.38M – 54
2020
Q2 		$3.38M Buy
+28,125
New +$3.96M 0.25% 37
2019
Q2 		– Sell
-79,862
Closed -$21M – 45
2019
Q1 		$21M Sell
79,862
-6,356
-7% -$1.1M 1.94% 18
2018
Q4 		$7.86M Sell
86,218
-9,913
-10% -$1.35M 0.79% 36
2018
Q3 		$18.5M Hold
96,131
– – 1.66% 19
2018
Q2 		$20.8M Buy
+96,131
New +$21.7M 1.98% 17

Other funds holding DNTH

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital's DNTH Position: Q3 2021 in Review

EcoR1 Capital sold out of Dianthus Therapeutics (DNTH) in Q3 2021, closing a stake of 22,929 shares — an estimated $3.59M sold.

EcoR1 Capital first reported a position in DNTH in Q2 2018 and held it in 7 quarters. The position peaked at $21M in Q1 2019. 93 funds tracked by Wall St. Rank hold DNTH as of Q3 2021.

  • EcoR1 Capital reported no remaining Dianthus Therapeutics position as of Q3 2021 after selling out during the quarter.
  • EcoR1 Capital sold 22,929 Dianthus Therapeutics shares in Q3 2021, an estimated $3.59M.
  • EcoR1 Capital first reported a position in Dianthus Therapeutics in Q2 2018 and held it in 7 quarters.
  • EcoR1 Capital's Dianthus Therapeutics position peaked at $21M in Q1 2019.
  • 93 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2021.

Based on EcoR1 Capital's 13F filing for Q3 2021, filed 15 Nov 2021.